Epilepsy Trial, Recruiting NCT07509190 Sponsor: Anny Reyes Condition: Epilepsy
Back to Epilepsy

Epilepsy Trial, Recruiting

NCT07509190
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Part 1 – Main study:

  • People aged 18 or older who have been diagnosed with epilepsy, have completed a surgical evaluation at Cleveland Clinic, and have been recommended for brain surgery or a neurostimulation device implant.

Part 2a – Patient survey:

  • People aged 18 or older who have been diagnosed with epilepsy, have been evaluated for epilepsy surgery, and have enough English proficiency to complete a survey.

Part 2a – Healthcare provider survey:

  • Healthcare professionals based in the US who are involved in the care or treatment of people with epilepsy.

Part 2b – Cleveland Clinic patient focus groups:

  • People aged 18 or older who have been diagnosed with epilepsy, have previously completed an epilepsy workup at Cleveland Clinic, have basic conversational English skills (assessed by phone), and have no signs of dementia or intellectual disability that would affect their ability to take part.

Part 2b – Cleveland Clinic provider focus groups:

  • Clinicians who are members of the Cleveland Clinic Epilepsy Center and care for patients with epilepsy.

Part 2b – Community patient focus groups:

  • People aged 18 or older who have been diagnosed with epilepsy, have previously completed an epilepsy workup (at any location), and have basic conversational English skills (assessed by phone), with no signs of dementia or intellectual disability that would affect participation.

Part 2b – Community provider focus groups:

  • Clinicians who provide care to people with epilepsy outside of Cleveland Clinic.

Part 3:

  • People aged 18 or older who are fluent in English and are currently being evaluated for epilepsy surgery at the Cleveland Clinic Epilepsy Monitoring Unit.

Who may not be able to join:

Part 1:

  • People who have previously had epilepsy surgery or already have a neurostimulation device implanted.

Part 2a – Patient survey:

  • People who are not able to read English fluently, or who have signs of dementia or intellectual disability that would affect their understanding of the survey questions.

Part 2a – Healthcare provider survey:

  • Healthcare providers who are not able to read English fluently.

Part 2b – Cleveland Clinic patient focus groups:

  • People who are not fluent in English, have signs of dementia or intellectual disability that would affect their ability to participate, or have previously had epilepsy surgery.

Part 2b – Cleveland Clinic provider focus groups:

  • Clinicians who were involved in designing this study.

Part 2b – Community patient focus groups:

  • People who are not fluent in English, have signs of dementia or intellectual disability that would affect their ability to participate, or have previously had epilepsy surgery.

Part 3:

  • People who are not fluent in English, or who have signs of dementia or intellectual disability that would affect their understanding of the study intervention.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Anny Reyes, PhD, The Cleveland Clinic

Phone: 216-390-4266

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Anny Reyes
Registry
ClinicalTrials.gov
Start date
18 March 2026
Est. completion
1 December 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Part 2a: Identify primary barriers to accessing and undergoing epilepsy surgery; Part 2b: Further identify barriers associated with lack of access and utilization of epilepsy surgery; Part 3: Determine acceptability of PEERS Program; Part 3: Determine satisfaction of PEERS Program; Part 3: Determine effectiveness of PEERS Program

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov